Contract HHSD200201692407C
Fresenius Kabi, Llc · Department Of Health And Human Services · September 23, 2021
Fresenius Kabi, Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 23, 2021 for $5.28 million of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $41.64 million.
Contract details
- PIID
- HHSD200201692407C
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- First action
- September 23, 2021
Description
EXTEND PERIOD OF PERFORMANCE AND ORDER ADDITIONAL PRODUCT
Modification timeline
-
September 23, 2021Mod P00009 · Supplemental Agreement For Work Within Scope$7.63M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Merck Sharp & Dohme Llc | Department Of Health And Human Services | March 27, 2026 | $361.34M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD200201692407C?
Contract HHSD200201692407C is a federal contract awarded to Fresenius Kabi, Llc by Department Of Health And Human Services on September 23, 2021 for $5.28 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HHSD200201692407C?
Fresenius Kabi, Llc won contract HHSD200201692407C from Department Of Health And Human Services.
How much is contract HHSD200201692407C worth?
Contract HHSD200201692407C has obligated $5.28 million to date, with a total potential value of $41.64 million if all options are exercised.